Total number of protein in "GO:0002250" GO term: 411
| Identifier | UniProt Gene | UniProt Accession | UniProt Name | Chromosome | GO term | Database | Cancer Driver | Number of missense mutations | Missense mutation per residues | Number of disordered residues | Number of mutations in disordered regions | Disordered missense mutations per residues | Number of OMIM mutation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ADGRE1-202 | ADGRE1 | Q14246 | Adhesion G protein-coupled receptor E1 | chr19 | GO:0002250 | Not Cancer Driver | No | 150 | 0.1693002257336343 | 15 | 4 | 0.0045146726862302 | 0 |
| AKIRIN2-201 | AKIRIN2 | Q53H80 | Akirin-2 | chr6 | GO:0002250 | Not Cancer Driver | No | 19 | 0.0935960591133004 | 124 | 11 | 0.0541871921182266 | 0 |
| ALCAM-201 | ALCAM | Q13740 | CD166 antigen | chr3 | GO:0002250 | Not Cancer Driver | No | 66 | 0.1132075471698113 | 97 | 12 | 0.0205831903945111 | 0 |
| ANXA1-201 | ANXA1 | P04083 | Annexin A1 | chr9 | GO:0002250 | Not Cancer Driver | No | 36 | 0.1040462427745664 | 61 | 7 | 0.0202312138728323 | 0 |
| ARG1-203 | ARG1 | P05089 | Arginase-1 | chr6 | GO:0002250 | Not Cancer Driver | No | 27 | 0.0838509316770186 | 83 | 8 | 0.0248447204968944 | 9 |
| ARG2-201 | ARG2 | P78540 | Arginase-2, mitochondrial | chr14 | GO:0002250 | Not Cancer Driver | No | 17 | 0.0480225988700565 | 58 | 2 | 0.0056497175141242 | 0 |
| BCL10-202 | BCL10 | O95999 | B-cell lymphoma/leukemia 10 | chr1 | GO:0002250 | Census, Compendium | Yes | 20 | 0.0858369098712446 | 153 | 14 | 0.0600858369098712 | 0 |
| BMX-202 | BMX | P51813 | Cytoplasmic tyrosine-protein kinase BMX | chrX | GO:0002250 | Not Cancer Driver | No | 74 | 0.1096296296296296 | 172 | 16 | 0.0237037037037037 | 0 |
| BTK-201 | BTK | Q06187 | Tyrosine-protein kinase BTK | chrX | GO:0002250 | Census, Compendium | Yes | 109 | 0.165402124430956 | 114 | 21 | 0.0318664643399089 | 83 |
| BTLA-201 | BTLA | Q7Z6A9 | B- and T-lymphocyte attenuator | chr3 | GO:0002250 | Not Cancer Driver | No | 21 | 0.0726643598615917 | 58 | 3 | 0.0103806228373702 | 0 |
| BTN3A1-202 | BTN3A1 | O00481 | Butyrophilin subfamily 3 member A1 | chr6 | GO:0002250 | Not Cancer Driver | No | 59 | 0.1150097465886939 | 72 | 13 | 0.0253411306042884 | 0 |
| BTNL8-202 | BTNL8 | Q6UX41 | Butyrophilin-like protein 8 | chr5 | GO:0002250 | Not Cancer Driver | No | 99 | 0.198 | 86 | 17 | 0.034 | 0 |
| C17orf99-201 | C17orf99 | Q6UX52 | Protein IL-40 | chr17 | GO:0002250 | Not Cancer Driver | No | 8 | 0.030188679245283 | 84 | 3 | 0.0113207547169811 | 0 |
| CAMK4-201 | CAMK4 | Q16566 | Calcium/calmodulin-dependent protein kinase type IV | chr5 | GO:0002250 | Not Cancer Driver | No | 67 | 0.1416490486257928 | 128 | 21 | 0.0443974630021141 | 0 |
| CD160-202 | CD160 | O95971 | CD160 antigen | chr1 | GO:0002250 | Not Cancer Driver | No | 16 | 0.0883977900552486 | 2 | 0 | 0.0 | 0 |
| CD1A-201 | CD1A | P06126 | T-cell surface glycoprotein CD1a | chr1 | GO:0002250 | Not Cancer Driver | No | 93 | 0.2844036697247706 | 18 | 5 | 0.0152905198776758 | 0 |
| CD1B-201 | CD1B | P29016 | T-cell surface glycoprotein CD1b | chr1 | GO:0002250 | Not Cancer Driver | No | 86 | 0.2582582582582582 | 7 | 0 | 0.0 | 0 |
| CD1C-201 | CD1C | P29017 | T-cell surface glycoprotein CD1c | chr1 | GO:0002250 | Not Cancer Driver | No | 99 | 0.2972972972972973 | 1 | 0 | 0.0 | 0 |
| CD1E-212 | CD1E | P15812 | T-cell surface glycoprotein CD1e, membrane-associated | chr1 | GO:0002250 | Not Cancer Driver | No | 144 | 0.3711340206185567 | 21 | 11 | 0.0283505154639175 | 0 |
| CD209-203 | CD209 | Q9NNX6 | CD209 antigen | chr19 | GO:0002250 | Census | Yes | 74 | 0.1831683168316831 | 42 | 5 | 0.0123762376237623 | 0 |
| CD244-202 | CD244 | Q9BZW8 | Natural killer cell receptor 2B4 | chr1 | GO:0002250 | Not Cancer Driver | No | 54 | 0.1459459459459459 | 93 | 16 | 0.0432432432432432 | 0 |
| CD247-201 | CD247 | P20963 | T-cell surface glycoprotein CD3 zeta chain | chr1 | GO:0002250 | Not Cancer Driver | No | 20 | 0.1219512195121951 | 92 | 14 | 0.0853658536585365 | 0 |
| CD274-202 | CD274 | Q9NZQ7 | Programmed cell death 1 ligand 1 | chr9 | GO:0002250 | Census | Yes | 26 | 0.0896551724137931 | 54 | 9 | 0.0310344827586206 | 0 |
| CD3D-201 | CD3D | P04234 | T-cell surface glycoprotein CD3 delta chain | chr11 | GO:0002250 | Not Cancer Driver | No | 19 | 0.1111111111111111 | 2 | 1 | 0.0058479532163742 | 0 |
| CD3E-201 | CD3E | P07766 | T-cell surface glycoprotein CD3 epsilon chain | chr11 | GO:0002250 | Not Cancer Driver | No | 16 | 0.0772946859903381 | 72 | 6 | 0.0289855072463768 | 0 |
| CD3G-206 | CD3G | P09693 | T-cell surface glycoprotein CD3 gamma chain | chr11 | GO:0002250 | Not Cancer Driver | No | 15 | 0.0824175824175824 | 49 | 5 | 0.0274725274725274 | 0 |
| CD4-201 | CD4 | P01730 | T-cell surface glycoprotein CD4 | chr12 | GO:0002250 | Not Cancer Driver | No | 50 | 0.1091703056768559 | 56 | 7 | 0.0152838427947598 | 0 |
| CD46-205 | CD46 | P15529 | Membrane cofactor protein | chr1 | GO:0002250 | Not Cancer Driver | No | 40 | 0.1020408163265306 | 52 | 4 | 0.010204081632653 | 5 |
| CD6-201 | CD6 | P30203 | T-cell differentiation antigen CD6 | chr11 | GO:0002250 | Not Cancer Driver | No | 70 | 0.1047904191616766 | 270 | 36 | 0.0538922155688622 | 0 |
| CD7-201 | CD7 | P09564 | T-cell antigen CD7 | chr17 | GO:0002250 | Not Cancer Driver | No | 21 | 0.0875 | 74 | 6 | 0.025 | 0 |
| CD79A-201 | CD79A | P11912 | B-cell antigen receptor complex-associated protein alpha chain | chr19 | GO:0002250 | Census | Yes | 20 | 0.0884955752212389 | 28 | 1 | 0.0044247787610619 | 0 |
| CD79B-201 | CD79B | P40259 | B-cell antigen receptor complex-associated protein beta chain | chr17 | GO:0002250 | Census, Compendium | Yes | 18 | 0.0786026200873362 | 43 | 10 | 0.0436681222707423 | 1 |
| CD84-201 | CD84 | Q9UIB8 | SLAM family member 5 | chr1 | GO:0002250 | Not Cancer Driver | No | 63 | 0.1826086956521739 | 52 | 8 | 0.0231884057971014 | 0 |
| CD86-202 | CD86 | P42081 | T-lymphocyte activation antigen CD86 | chr3 | GO:0002250 | Not Cancer Driver | No | 64 | 0.1945288753799392 | 56 | 10 | 0.0303951367781155 | 0 |
| CD8A-201 | CD8A | P01732 | T-cell surface glycoprotein CD8 alpha chain | chr2 | GO:0002250 | Not Cancer Driver | No | 27 | 0.1148936170212766 | 28 | 2 | 0.0085106382978723 | 1 |
| CD8B-203 | CD8B | P10966 | T-cell surface glycoprotein CD8 beta chain | chr2 | GO:0002250 | Not Cancer Driver | No | 33 | 0.1571428571428571 | 10 | 0 | 0.0 | 0 |
| CD8B2-202 | CD8B2 | A6NJW9 | T-cell surface glycoprotein CD8 beta-2 chain | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 10 | 0 | 0.0 | 0 |
| CLEC10A-201 | CLEC10A | Q8IUN9 | C-type lectin domain family 10 member A | chr17 | GO:0002250 | Not Cancer Driver | No | 34 | 0.1075949367088607 | 43 | 5 | 0.0158227848101265 | 0 |
| CLEC4A-201 | CLEC4A | Q9UMR7 | C-type lectin domain family 4 member A | chr12 | GO:0002250 | Not Cancer Driver | No | 24 | 0.1012658227848101 | 22 | 4 | 0.0168776371308016 | 0 |
| CLEC4C-202 | CLEC4C | Q8WTT0 | C-type lectin domain family 4 member C | chr12 | GO:0002250 | Not Cancer Driver | No | 45 | 0.2112676056338028 | 5 | 1 | 0.0046948356807511 | 0 |
| CLEC4D-201 | CLEC4D | Q8WXI8 | C-type lectin domain family 4 member D | chr12 | GO:0002250 | Not Cancer Driver | No | 52 | 0.241860465116279 | 18 | 3 | 0.013953488372093 | 0 |
| CLEC4M-201 | CLEC4M | Q9H2X3 | C-type lectin domain family 4 member M | chr19 | GO:0002250 | Not Cancer Driver | No | 54 | 0.1353383458646616 | 40 | 9 | 0.0225563909774436 | 0 |
| CLEC6A-201 | CLEC6A | Q6EIG7 | C-type lectin domain family 6 member A | chr12 | GO:0002250 | Not Cancer Driver | No | 34 | 0.1626794258373205 | 7 | 0 | 0.0 | 0 |
| CRACR2A-203 | CRACR2A | Q9BSW2 | EF-hand calcium-binding domain-containing protein 4B | chr12 | GO:0002250 | Not Cancer Driver | No | 65 | 0.0889192886456908 | 443 | 42 | 0.0574555403556771 | 0 |
| CSK-201 | CSK | P41240 | Tyrosine-protein kinase CSK | chr15 | GO:0002250 | Not Cancer Driver | No | 37 | 0.0822222222222222 | 18 | 1 | 0.0022222222222222 | 0 |
| CTLA4-204 | CTLA4 | P16410 | Cytotoxic T-lymphocyte protein 4 | chr2 | GO:0002250 | Not Cancer Driver | No | 28 | 0.1255605381165919 | 3 | 0 | 0.0 | 1 |
| CTNNBL1-201 | CTNNBL1 | Q8WYA6 | Beta-catenin-like protein 1 | chr20 | GO:0002250 | Not Cancer Driver | No | 53 | 0.0941385435168739 | 158 | 18 | 0.0319715808170515 | 1 |
| CTSH-201 | CTSH | P09668 | Pro-cathepsin H | chr15 | GO:0002250 | Not Cancer Driver | No | 35 | 0.1044776119402985 | 4 | 0 | 0.0 | 0 |
| CTSL-203 | CTSL | P07711 | Procathepsin L | chr9 | GO:0002250 | Not Cancer Driver | No | 36 | 0.1081081081081081 | 34 | 5 | 0.015015015015015 | 0 |
| CTSS-201 | CTSS | P25774 | Cathepsin S | chr1 | GO:0002250 | Not Cancer Driver | No | 40 | 0.120845921450151 | 0 | 0 | 0.0 | 0 |
| CX3CR1-202 | CX3CR1 | P49238 | CX3C chemokine receptor 1 | chr3 | GO:0002250 | Not Cancer Driver | No | 60 | 0.1690140845070422 | 0 | 0 | 0.0 | 0 |
| DBNL-210 | DBNL | Q9UJU6 | Drebrin-like protein | chr7 | GO:0002250 | Not Cancer Driver | No | 39 | 0.0906976744186046 | 306 | 25 | 0.0581395348837209 | 0 |
| DCLRE1C-209 | DCLRE1C | Q96SD1 | Protein artemis | chr10 | GO:0002250 | Not Cancer Driver | No | 56 | 0.0809248554913294 | 277 | 21 | 0.0303468208092485 | 3 |
| EIF2AK4-201 | EIF2AK4 | Q9P2K8 | eIF-2-alpha kinase GCN2 | chr15 | GO:0002250 | Not Cancer Driver | No | 113 | 0.0685263796240145 | 496 | 34 | 0.0206185567010309 | 2 |
| EOMES-201 | EOMES | O95936 | Eomesodermin homolog | chr3 | GO:0002250 | Not Cancer Driver | No | 64 | 0.0932944606413994 | 435 | 41 | 0.0597667638483965 | 0 |
| ERAP1-202 | ERAP1 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | chr5 | GO:0002250 | Not Cancer Driver | No | 57 | 0.0605738575982996 | 70 | 1 | 0.0010626992561105 | 0 |
| ERAP2-202 | ERAP2 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | chr5 | GO:0002250 | Not Cancer Driver | No | 73 | 0.0760416666666666 | 23 | 4 | 0.0041666666666666 | 0 |
| FBXO38-202 | FBXO38 | Q6PIJ6 | F-box only protein 38 | chr5 | GO:0002250 | Not Cancer Driver | No | 94 | 0.0791245791245791 | 441 | 33 | 0.0277777777777777 | 1 |
| FCAMR-201 | FCAMR | Q8WWV6 | High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor | chr1 | GO:0002250 | Not Cancer Driver | No | 47 | 0.0814558058925476 | 369 | 25 | 0.0433275563258232 | 0 |
| FCRL4-201 | FCRL4 | Q96PJ5 | Fc receptor-like protein 4 | chr1 | GO:0002250 | Census | Yes | 113 | 0.2194174757281553 | 174 | 45 | 0.087378640776699 | 0 |
| FGA-202 | FGA | P02671 | Fibrinogen alpha chain | chr4 | GO:0002250 | Not Cancer Driver | No | 179 | 0.2066974595842956 | 523 | 113 | 0.1304849884526558 | 7 |
| FGB-201 | FGB | P02675 | Fibrinogen beta chain | chr4 | GO:0002250 | Not Cancer Driver | No | 75 | 0.1527494908350305 | 144 | 31 | 0.0631364562118126 | 7 |
| FGL1-205 | FGL1 | Q08830 | Fibrinogen-like protein 1 | chr8 | GO:0002250 | Not Cancer Driver | No | 28 | 0.0897435897435897 | 10 | 2 | 0.0064102564102564 | 0 |
| FYN-202 | FYN | P06241 | Tyrosine-protein kinase Fyn | chr6 | GO:0002250 | Not Cancer Driver | No | 64 | 0.1191806331471136 | 71 | 11 | 0.0204841713221601 | 0 |
| GPR183-201 | GPR183 | P32249 | G-protein coupled receptor 183 | chr13 | GO:0002250 | Not Cancer Driver | No | 35 | 0.0969529085872576 | 25 | 3 | 0.0083102493074792 | 0 |
| HAVCR2-201 | HAVCR2 | Q8TDQ0 | Hepatitis A virus cellular receptor 2 | chr5 | GO:0002250 | Not Cancer Driver | No | 45 | 0.1495016611295681 | 17 | 1 | 0.0033222591362126 | 3 |
| HLA-B-249 | HLA-B | P01889 | HLA class I histocompatibility antigen, B alpha chain | chr6 | GO:0002250 | Compendium | Yes | 49 | 0.1353591160220994 | 169 | 18 | 0.0497237569060773 | 0 |
| HLA-C-201 | HLA-C | P10321 | HLA class I histocompatibility antigen, C alpha chain | chr6 | GO:0002250 | Not Cancer Driver | No | 36 | 0.0983606557377049 | 175 | 14 | 0.0382513661202185 | 0 |
| HLA-DMA-201 | HLA-DMA | P28067 | HLA class II histocompatibility antigen, DM alpha chain | chr6 | GO:0002250 | Not Cancer Driver | No | 21 | 0.0804597701149425 | 16 | 0 | 0.0 | 0 |
| HLA-DMB-258 | HLA-DMB | P28068 | HLA class II histocompatibility antigen, DM beta chain | chr6 | GO:0002250 | Not Cancer Driver | No | 32 | 0.1216730038022813 | 41 | 6 | 0.0228136882129277 | 0 |
| HLA-DOA-201 | HLA-DOA | P06340 | HLA class II histocompatibility antigen, DO alpha chain | chr6 | GO:0002250 | Not Cancer Driver | No | 27 | 0.108 | 7 | 1 | 0.004 | 0 |
| HLA-DOB-206 | HLA-DOB | P13765 | HLA class II histocompatibility antigen, DO beta chain | chr6 | GO:0002250 | Not Cancer Driver | No | 21 | 0.0769230769230769 | 9 | 1 | 0.0036630036630036 | 0 |
| HLA-DPA1-248 | HLA-DPA1 | P20036 | HLA class II histocompatibility antigen, DP alpha 1 chain | chr6 | GO:0002250 | Not Cancer Driver | No | 22 | 0.0846153846153846 | 30 | 3 | 0.0115384615384615 | 0 |
| HLA-DPB1-211 | HLA-DPB1 | P04440 | HLA class II histocompatibility antigen, DP beta 1 chain | chr6 | GO:0002250 | Not Cancer Driver | No | 14 | 0.0542635658914728 | 39 | 4 | 0.0155038759689922 | 0 |
| HLA-DQA2-210 | HLA-DQA2 | P01906 | HLA class II histocompatibility antigen, DQ alpha 2 chain | chr6 | GO:0002250 | Not Cancer Driver | No | 44 | 0.1725490196078431 | 7 | 0 | 0.0 | 0 |
| HLA-DQB1-205 | HLA-DQB1 | P01920 | HLA class II histocompatibility antigen, DQ beta 1 chain | chr6 | GO:0002250 | Not Cancer Driver | No | 17 | 0.0651340996168582 | 25 | 1 | 0.003831417624521 | 0 |
| HLA-DQB2-232 | HLA-DQB2 | P05538 | HLA class II histocompatibility antigen, DQ beta 2 chain | chr6 | GO:0002250 | Not Cancer Driver | No | 17 | 0.0643939393939393 | 38 | 2 | 0.0075757575757575 | 0 |
| HLA-DRA-202 | HLA-DRA | P01903 | HLA class II histocompatibility antigen, DR alpha chain | chr6 | GO:0002250 | Not Cancer Driver | No | 43 | 0.1692913385826771 | 12 | 2 | 0.0078740157480314 | 0 |
| HLA-DRB5-201 | HLA-DRB5 | Q30154 | HLA class II histocompatibility antigen, DR beta 5 chain | chr6 | GO:0002250 | Not Cancer Driver | No | 7 | 0.0263157894736842 | 19 | 0 | 0.0 | 0 |
| HLA-E-201 | HLA-E | P13747 | HLA class I histocompatibility antigen, alpha chain E | chr6 | GO:0002250 | Not Cancer Driver | No | 40 | 0.1117318435754189 | 140 | 22 | 0.0614525139664804 | 0 |
| HMHB1-201 | HMHB1 | O97980 | Minor histocompatibility protein HB-1 | chr5 | GO:0002250 | Not Cancer Driver | No | 1 | 0.024390243902439 | 10 | 0 | 0.0 | 0 |
| ICOSLG-204 | ICOSLG | O75144 | ICOS ligand | chr21 | GO:0002250 | Not Cancer Driver | No | 20 | 0.0662251655629139 | 29 | 2 | 0.0066225165562913 | 0 |
| IFNA1-201 | IFNA13 | P01562 | Interferon alpha-1/13 | chr9 | GO:0002250 | Not Cancer Driver | No | 23 | 0.1216931216931216 | 2 | 1 | 0.0052910052910052 | 0 |
| IFNA10-201 | IFNA10 | P01566 | Interferon alpha-10 | chr9 | GO:0002250 | Not Cancer Driver | No | 25 | 0.1322751322751322 | 1 | 0 | 0.0 | 0 |
| IFNA13-202 | IFNA13 | P01562 | Interferon alpha-1/13 | chr9 | GO:0002250 | Not Cancer Driver | No | 29 | 0.1526315789473684 | 2 | 0 | 0.0 | 0 |
| IFNA14-201 | IFNA14 | P01570 | Interferon alpha-14 | chr9 | GO:0002250 | Not Cancer Driver | No | 27 | 0.1428571428571428 | 1 | 1 | 0.0052910052910052 | 0 |
| IFNA16-201 | IFNA16 | P05015 | Interferon alpha-16 | chr9 | GO:0002250 | Not Cancer Driver | No | 51 | 0.2698412698412698 | 1 | 0 | 0.0 | 0 |
| IFNA17-201 | IFNA17 | P01571 | Interferon alpha-17 | chr9 | GO:0002250 | Not Cancer Driver | No | 29 | 0.1534391534391534 | 0 | 0 | 0.0 | 0 |
| IFNA2-201 | IFNA2 | P01563 | Interferon alpha-2 | chr9 | GO:0002250 | Not Cancer Driver | No | 24 | 0.1276595744680851 | 2 | 0 | 0.0 | 0 |
| IFNA21-201 | IFNA21 | P01568 | Interferon alpha-21 | chr9 | GO:0002250 | Not Cancer Driver | No | 23 | 0.1216931216931216 | 0 | 0 | 0.0 | 0 |
| IFNA4-201 | IFNA4 | P05014 | Interferon alpha-4 | chr9 | GO:0002250 | Not Cancer Driver | No | 30 | 0.1587301587301587 | 1 | 0 | 0.0 | 0 |
| IFNA5-201 | IFNA5 | P01569 | Interferon alpha-5 | chr9 | GO:0002250 | Not Cancer Driver | No | 27 | 0.1428571428571428 | 1 | 0 | 0.0 | 0 |
| IFNA6-202 | IFNA6 | P05013 | Interferon alpha-6 | chr9 | GO:0002250 | Not Cancer Driver | No | 21 | 0.1111111111111111 | 4 | 0 | 0.0 | 0 |
| IFNA7-201 | IFNA7 | P01567 | Interferon alpha-7 | chr9 | GO:0002250 | Not Cancer Driver | No | 33 | 0.1746031746031746 | 1 | 1 | 0.0052910052910052 | 0 |
| IFNA8-201 | IFNA8 | P32881 | Interferon alpha-8 | chr9 | GO:0002250 | Not Cancer Driver | No | 33 | 0.1746031746031746 | 0 | 0 | 0.0 | 0 |
| IFNB1-201 | IFNB1 | P01574 | Interferon beta | chr9 | GO:0002250 | Not Cancer Driver | No | 29 | 0.1550802139037433 | 0 | 0 | 0.0 | 0 |
| IFNE-201 | IFNE | Q86WN2 | Interferon epsilon | chr9 | GO:0002250 | Not Cancer Driver | No | 22 | 0.1057692307692307 | 17 | 3 | 0.0144230769230769 | 0 |
| IFNG-201 | IFNG | P01579 | Interferon gamma | chr12 | GO:0002250 | Not Cancer Driver | No | 34 | 0.2048192771084337 | 23 | 3 | 0.0180722891566265 | 0 |
| IFNK-201 | IFNK | Q9P0W0 | Interferon kappa | chr9 | GO:0002250 | Not Cancer Driver | No | 13 | 0.0628019323671497 | 24 | 0 | 0.0 | 0 |
| IFNW1-201 | IFNW1 | P05000 | Interferon omega-1 | chr9 | GO:0002250 | Not Cancer Driver | No | 28 | 0.1435897435897435 | 10 | 3 | 0.0153846153846153 | 0 |
| IGHA1-202 | IGHA1 | P01876 | Immunoglobulin heavy constant alpha 1 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGHA2-202 | IGHA2 | P01877 | Immunoglobulin heavy constant alpha 2 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGHD-201 | IGHD | P01880 | Immunoglobulin heavy constant delta | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGHE-202 | IGHE | P01854 | Immunoglobulin heavy constant epsilon | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGHG1-202 | IGHG1 | P01857 | Immunoglobulin heavy constant gamma 1 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGHG2-202 | IGHG2 | P01859 | Immunoglobulin heavy constant gamma 2 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGHG3-202 | IGHG3 | P01860 | Immunoglobulin heavy constant gamma 3 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGHG4-202 | IGHG4 | P01861 | Immunoglobulin heavy constant gamma 4 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGHJ1-201 | IGHJ1 | A0A0C4DH62 | Immunoglobulin heavy joining 1 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGHM-202 | IGHM | P01871 | Immunoglobulin heavy constant mu | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGHV3OR16-9-201 | IGHV3OR16-9 | A0A0B4J2B5 | Immunoglobulin heavy variable 3/OR16-9 (non-functional) (Fragment) | chr16 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKC-201 | IGKC | P01834 | Immunoglobulin kappa constant | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKJ1-201 | IGKJ1 | A0A0A0MT89 | Immunoglobulin kappa joining 1 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1-12-201 | IGKV1-12 | A0A0C4DH73 | Immunoglobulin kappa variable 1-12 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1-16-201 | IGKV1-16 | P04430 | Immunoglobulin kappa variable 1-16 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1-17-201 | IGKV1-17 | P01599 | Immunoglobulin kappa variable 1-17 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1-27-201 | IGKV1-27 | A0A075B6S5 | Immunoglobulin kappa variable 1-27 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1-33-201 | IGKV1-33 | P01594 | Immunoglobulin kappa variable 1-33 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1-37-201 | IGKV1-37 | A0A075B6S9 | Probable non-functional immunoglobulinn kappa variable 1-37 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1-39-201 | IGKV1-39 | P01597 | Immunoglobulin kappa variable 1-39 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1-5-201 | IGKV1-5 | P01602 | Immunoglobulin kappa variable 1-5 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1-6-201 | IGKV1-6 | A0A0C4DH72 | Immunoglobulin kappa variable 1-6 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1-8-201 | IGKV1-8 | A0A0C4DH67 | Immunoglobulin kappa variable 1-8 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1-9-201 | IGKV1-9 | A0A0C4DH69 | Immunoglobulin kappa variable 1-9 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1D-12-201 | IGKV1D-12 | P01611 | Immunoglobulin kappa variable 1D-12 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1D-13-201 | IGKV1-13 | P0DP09 | Immunoglobulin kappa variable 1-13 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1D-16-201 | IGKV1D-16 | P01601 | Immunoglobulin kappa variable 1D-16 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1D-17-201 | IGKV1D-17 | A0A075B6S4 | Immunoglobulin kappa variable 1D-17 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1D-33-201 | IGKV1-33 | P01594 | Immunoglobulin kappa variable 1-33 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1D-37-201 | IGKV1-37 | A0A075B6S9 | Probable non-functional immunoglobulinn kappa variable 1-37 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1D-39-201 | IGKV1-39 | P01597 | Immunoglobulin kappa variable 1-39 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1D-42-201 | IGKV1D-42 | A0A075B6H8 | Probable non-functional immunoglobulin kappa variable 1D-42 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1D-43-201 | IGKV1D-43 | A0A0B4J1Z2 | Immunoglobulin kappa variable 1D-43 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV1D-8-201 | IGKV1D-8 | A0A087WSZ0 | Immunoglobulin kappa variable 1D-8 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV2-24-201 | IGKV2-24 | A0A0C4DH68 | Immunoglobulin kappa variable 2-24 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV2-28-201 | IGKV2D-28 | P01615 | Immunoglobulin kappa variable 2D-28 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV2-30-201 | IGKV2-30 | P06310 | Immunoglobulin kappa variable 2-30 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV2D-24-201 | IGKV2D-24 | A0A075B6R9 | Probable non-functional immunoglobulin kappa variable 2D-24 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV2D-26-201 | IGKV2D-26 | A0A0A0MRZ7 | Immunoglobulin kappa variable 2D-26 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV2D-28-201 | IGKV2D-28 | P01615 | Immunoglobulin kappa variable 2D-28 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV2D-29-201 | IGKV2D-29 | A0A075B6S2 | Immunoglobulin kappa variable 2D-29 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV2D-30-201 | IGKV2D-30 | A0A075B6S6 | Immunoglobulin kappa variable 2D-30 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV2D-40-201 | IGKV2-40 | A0A087WW87 | Immunoglobulin kappa variable 2-40 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV3-11-201 | IGKV3-11 | P04433 | Immunoglobulin kappa variable 3-11 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV3-15-201 | IGKV3-15 | P01624 | Immunoglobulin kappa variable 3-15 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV3-20-201 | IGKV3-20 | P01619 | Immunoglobulin kappa variable 3-20 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV3-7-201 | IGKV3-7 | A0A075B6H7 | Probable non-functional immunoglobulin kappa variable 3-7 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV3D-11-201 | IGKV3D-11 | A0A0A0MRZ8 | Immunoglobulin kappa variable 3D-11 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV3D-15-201 | IGKV3D-15 | A0A087WSY6 | Immunoglobulin kappa variable 3D-15 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV3D-20-201 | IGKV3D-20 | A0A0C4DH25 | Immunoglobulin kappa variable 3D-20 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV3D-7-201 | IGKV3D-7 | A0A0C4DH55 | Immunoglobulin kappa variable 3D-7 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV4-1-201 | IGKV4-1 | P06312 | Immunoglobulin kappa variable 4-1 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV5-2-201 | IGKV5-2 | P06315 | Immunoglobulin kappa variable 5-2 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV6-21-201 | IGKV6-21 | A0A0C4DH24 | Immunoglobulin kappa variable 6-21 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV6D-21-201 | IGKV6D-21 | A0A0A0MT36 | Immunoglobulin kappa variable 6D-21 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGKV6D-41-201 | IGKV6D-41 | A0A0C4DH26 | Probable non-functional immunoglobulin kappa variable 6D-41 | chr2 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLC1-201 | IGLC1 | P0CG04 | Immunoglobulin lambda constant 1 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLC3-201 | IGLC3 | P0DOY3 | Immunoglobulin lambda constant 3 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLC7-201 | IGLC7 | A0M8Q6 | Immunoglobulin lambda constant 7 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLJ1-201 | IGLJ1 | A0A0A0MT76 | Immunoglobulin lambda joining 1 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV1-36-201 | IGLV1-36 | A0A0B4J1U3 | Immunoglobulin lambda variable 1-36 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV1-40-201 | IGLV1-40 | P01703 | Immunoglobulin lambda variable 1-40 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV1-44-201 | IGLV1-44 | P01699 | Immunoglobulin lambda variable 1-44 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV1-47-201 | IGLV1-47 | P01700 | Immunoglobulin lambda variable 1-47 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV1-50-201 | IGLV1-50 | A0A075B6I6 | Probable non-functional immunoglobulin lambda variable 1-50 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV1-51-201 | IGLV1-51 | P01701 | Immunoglobulin lambda variable 1-51 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV10-54-201 | IGLV10-54 | A0A075B6I4 | Immunoglobulin lambda variable 10-54 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV11-55-201 | IGLV11-55 | A0A075B6I3 | Probable non-functional immunoglobulin lambda variable 11-55 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV2-11-201 | IGLV2-11 | P01706 | Immunoglobulin lambda variable 2-11 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV2-14-201 | IGLV2-14 | P01704 | Immunoglobulin lambda variable 2-14 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV2-18-201 | IGLV2-18 | A0A075B6J9 | Immunoglobulin lambda variable 2-18 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV2-23-201 | IGLV2-23 | P01705 | Immunoglobulin lambda variable 2-23 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV2-33-201 | IGLV2-33 | A0A075B6J2 | Probable non-functional immunoglobulin lambda variable 2-33 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV2-8-201 | IGLV2-8 | P01709 | Immunoglobulin lambda variable 2-8 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV3-1-201 | IGLV3-1 | P01715 | Immunoglobulin lambda variable 3-1 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV3-10-201 | IGLV3-10 | A0A075B6K4 | Immunoglobulin lambda variable 3-10 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV3-12-201 | IGLV3-12 | A0A075B6K2 | Immunoglobulin lambda variable 3-12 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV3-16-201 | IGLV3-16 | A0A075B6K0 | Immunoglobulin lambda variable 3-16 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV3-19-201 | IGLV3-19 | P01714 | Immunoglobulin lambda variable 3-19 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV3-21-201 | IGLV3-21 | P80748 | Immunoglobulin lambda variable 3-21 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV3-22-201 | IGLV3-22 | A0A075B6J6 | Immunoglobulin lambda variable 3-22 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV3-25-201 | IGLV3-25 | P01717 | Immunoglobulin lambda variable 3-25 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV3-27-201 | IGLV3-27 | P01718 | Immunoglobulin lambda variable 3-27 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV3-32-201 | IGLV3-32 | A0A0A0MS00 | Probable non-functional immunoglobulin lambda variable 3-32 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV3-9-201 | IGLV3-9 | A0A075B6K5 | Immunoglobulin lambda variable 3-9 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV4-3-201 | IGLV4-3 | A0A075B6K6 | Immunoglobulin lambda variable 4-3 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV4-60-201 | IGLV4-60 | A0A075B6I1 | Immunoglobulin lambda variable 4-60 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV4-69-201 | IGLV4-69 | A0A075B6H9 | Immunoglobulin lambda variable 4-69 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV5-37-201 | IGLV5-37 | A0A075B6J1 | Immunoglobulin lambda variable 5-37 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV5-45-201 | IGLV5-45 | A0A087WSX0 | Immunoglobulin lambda variable 5-45 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV5-48-201 | IGLV5-48 | A0A075B6I7 | Probable non-functional immunoglobulin lambda variable 5-48 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV5-52-201 | IGLV5-52 | A0A0A0MRZ9 | Immunoglobulin lambda variable 5-52 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV6-57-201 | IGLV6-57 | P01721 | Immunoglobulin lambda variable 6-57 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV7-43-201 | IGLV7-43 | P04211 | Immunoglobulin lambda variable 7-43 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV7-46-201 | IGLV7-46 | A0A075B6I9 | Immunoglobulin lambda variable 7-46 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV8-61-201 | IGLV8-61 | A0A075B6I0 | Immunoglobulin lambda variable 8-61 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IGLV9-49-201 | IGLV9-49 | A0A0B4J1Y8 | Immunoglobulin lambda variable 9-49 | chr22 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| IL17A-201 | IL17A | Q16552 | Interleukin-17A | chr6 | GO:0002250 | Not Cancer Driver | No | 45 | 0.2903225806451613 | 56 | 16 | 0.1032258064516129 | 0 |
| IL17F-201 | IL17F | Q96PD4 | Interleukin-17F | chr6 | GO:0002250 | Not Cancer Driver | No | 33 | 0.2024539877300613 | 34 | 8 | 0.0490797546012269 | 1 |
| IL2-201 | IL2 | P60568 | Interleukin-2 | chr4 | GO:0002250 | Census | Yes | 16 | 0.1045751633986928 | 6 | 0 | 0.0 | 0 |
| IL4I1-202 | IL4I1 | Q96RQ9 | L-amino-acid oxidase | chr19 | GO:0002250 | Not Cancer Driver | No | 44 | 0.0776014109347442 | 136 | 10 | 0.0176366843033509 | 0 |
| ITK-201 | ITK | Q08881 | Tyrosine-protein kinase ITK/TSK | chr5 | GO:0002250 | Census | Yes | 106 | 0.1709677419354838 | 43 | 9 | 0.014516129032258 | 1 |
| JAK2-201 | JAK2 | O60674 | Tyrosine-protein kinase JAK2 | chr9 | GO:0002250 | Census, Compendium | Yes | 81 | 0.0715547703180212 | 59 | 4 | 0.0035335689045936 | 4 |
| JAK3-201 | JAK3 | P52333 | Tyrosine-protein kinase JAK3 | chr19 | GO:0002250 | Census, Compendium | Yes | 131 | 0.1165480427046263 | 63 | 4 | 0.0035587188612099 | 7 |
| JAM3-201 | JAM3 | Q9BX67 | Junctional adhesion molecule C | chr11 | GO:0002250 | Not Cancer Driver | No | 34 | 0.1096774193548387 | 62 | 8 | 0.0258064516129032 | 2 |
| JCHAIN-201 | JCHAIN | P01591 | Immunoglobulin J chain | chr4 | GO:0002250 | Not Cancer Driver | No | 25 | 0.1572327044025157 | 9 | 2 | 0.0125786163522012 | 0 |
| KCNJ8-201 | KCNJ8 | Q15842 | ATP-sensitive inward rectifier potassium channel 8 | chr12 | GO:0002250 | Not Cancer Driver | No | 78 | 0.1839622641509433 | 69 | 17 | 0.0400943396226415 | 1 |
| KLRC1-202 | KLRC1 | P26715 | NKG2-A/NKG2-B type II integral membrane protein | chr12 | GO:0002250 | Not Cancer Driver | No | 33 | 0.1416309012875536 | 50 | 6 | 0.0257510729613733 | 0 |
| KLRC2-202 | KLRC2 | P26717 | NKG2-C type II integral membrane protein | chr12 | GO:0002250 | Not Cancer Driver | No | 38 | 0.1645021645021645 | 45 | 11 | 0.0476190476190476 | 0 |
| KLRD1-201 | KLRD1 | Q13241 | Natural killer cells antigen CD94 | chr12 | GO:0002250 | Not Cancer Driver | No | 24 | 0.1340782122905028 | 0 | 0 | 0.0 | 0 |
| KLRK1-201 | KLRK1 | P26718 | NKG2-D type II integral membrane protein | chr12 | GO:0002250 | Not Cancer Driver | No | 35 | 0.162037037037037 | 0 | 0 | 0.0 | 0 |
| LAG3-201 | LAG3 | P18627 | Lymphocyte activation gene 3 protein | chr12 | GO:0002250 | Not Cancer Driver | No | 37 | 0.0704761904761904 | 208 | 10 | 0.019047619047619 | 0 |
| LAIR1-203 | LAIR1 | Q6GTX8 | Leukocyte-associated immunoglobulin-like receptor 1 | chr19 | GO:0002250 | Not Cancer Driver | No | 58 | 0.2020905923344947 | 179 | 38 | 0.1324041811846689 | 0 |
| LAMP3-201 | LAMP3 | Q9UQV4 | Lysosome-associated membrane glycoprotein 3 | chr3 | GO:0002250 | Not Cancer Driver | No | 57 | 0.1370192307692307 | 223 | 34 | 0.0817307692307692 | 0 |
| LAT-201 | LAT | O43561 | Linker for activation of T-cells family member 1 | chr16 | GO:0002250 | Not Cancer Driver | No | 20 | 0.0763358778625954 | 213 | 19 | 0.0725190839694656 | 0 |
| LAT2-205 | LAT2 | Q9GZY6 | Linker for activation of T-cells family member 2 | chr7 | GO:0002250 | Not Cancer Driver | No | 30 | 0.1234567901234567 | 176 | 22 | 0.0905349794238683 | 0 |
| LAX1-203 | LAX1 | Q8IWV1 | Lymphocyte transmembrane adapter 1 | chr1 | GO:0002250 | Not Cancer Driver | No | 50 | 0.1256281407035175 | 230 | 24 | 0.0603015075376884 | 0 |
| LILRA1-201 | LILRA1 | O75019 | Leukocyte immunoglobulin-like receptor subfamily A member 1 | chr19 | GO:0002250 | Not Cancer Driver | No | 131 | 0.2678936605316973 | 78 | 21 | 0.0429447852760736 | 0 |
| LILRA6-203 | LILRA6 | Q6PI73 | Leukocyte immunoglobulin-like receptor subfamily A member 6 | chr19 | GO:0002250 | Not Cancer Driver | No | 100 | 0.2079002079002079 | 160 | 32 | 0.0665280665280665 | 0 |
| LILRB1-201 | LILRB1 | Q8NHL6 | Leukocyte immunoglobulin-like receptor subfamily B member 1 | chr19 | GO:0002250 | Not Cancer Driver | No | 170 | 0.2607361963190184 | 325 | 86 | 0.1319018404907975 | 0 |
| LILRB2-201 | LILRB2 | Q8N423 | Leukocyte immunoglobulin-like receptor subfamily B member 2 | chr19 | GO:0002250 | Not Cancer Driver | No | 120 | 0.2010050251256281 | 235 | 41 | 0.0686767169179229 | 0 |
| LILRB3-206 | LILRB3 | O75022 | Leukocyte immunoglobulin-like receptor subfamily B member 3 | chr19 | GO:0002250 | Not Cancer Driver | No | 54 | 0.0855784469096671 | 296 | 39 | 0.0618066561014263 | 0 |
| LILRB4-211 | LILRB4 | Q8NHJ6 | Leukocyte immunoglobulin-like receptor subfamily B member 4 | chr19 | GO:0002250 | Not Cancer Driver | No | 122 | 0.2723214285714285 | 276 | 88 | 0.1964285714285714 | 0 |
| LILRB5-201 | LILRB5 | O75023 | Leukocyte immunoglobulin-like receptor subfamily B member 5 | chr19 | GO:0002250 | Not Cancer Driver | No | 123 | 0.2084745762711864 | 202 | 57 | 0.0966101694915254 | 0 |
| LIME1-201 | LIME1 | Q9H400 | Lck-interacting transmembrane adapter 1 | chr20 | GO:0002250 | Not Cancer Driver | No | 20 | 0.0677966101694915 | 193 | 14 | 0.047457627118644 | 0 |
| LYN-202 | LYN | P07948 | Tyrosine-protein kinase Lyn | chr8 | GO:0002250 | Census | Yes | 78 | 0.15234375 | 85 | 10 | 0.01953125 | 0 |
| MARCHF8-201 | MARCHF8 | Q5T0T0 | E3 ubiquitin-protein ligase MARCHF8 | chr10 | GO:0002250 | Not Cancer Driver | No | 25 | 0.0859106529209622 | 71 | 8 | 0.0274914089347079 | 0 |
| MCOLN1-201 | MCOLN1 | Q9GZU1 | Mucolipin-1 | chr19 | GO:0002250 | Not Cancer Driver | No | 55 | 0.0948275862068965 | 63 | 12 | 0.0206896551724137 | 7 |
| MCOLN2-202 | MCOLN2 | Q8IZK6 | Mucolipin-2 | chr1 | GO:0002250 | Not Cancer Driver | No | 65 | 0.1148409893992932 | 0 | 0 | 0.0 | 0 |
| MICB-201 | MICB | Q29980 | MHC class I polypeptide-related sequence B | chr6 | GO:0002250 | Not Cancer Driver | No | 41 | 0.1070496083550913 | 175 | 16 | 0.04177545691906 | 0 |
| MPEG1-201 | MPEG1 | Q2M385 | Macrophage-expressed gene 1 protein | chr11 | GO:0002250 | Not Cancer Driver | No | 102 | 0.1424581005586592 | 101 | 20 | 0.0279329608938547 | 0 |
| NLRP10-202 | NLRP10 | Q86W26 | NACHT, LRR and PYD domains-containing protein 10 | chr11 | GO:0002250 | Not Cancer Driver | No | 156 | 0.2381679389312977 | 96 | 24 | 0.0366412213740458 | 0 |
| NOD2-201 | NOD2 | Q9HC29 | Nucleotide-binding oligomerization domain-containing protein 2 | chr16 | GO:0002250 | Not Cancer Driver | No | 130 | 0.125 | 41 | 3 | 0.0028846153846153 | 15 |
| ORAI1-202 | ORAI1 | Q96D31 | Calcium release-activated calcium channel protein 1 | chr12 | GO:0002250 | Not Cancer Driver | No | 19 | 0.0631229235880398 | 101 | 6 | 0.0199335548172757 | 5 |
| OTUB1-208 | OTUB1 | Q96FW1 | Ubiquitin thioesterase OTUB1 | chr11 | GO:0002250 | Not Cancer Driver | No | 25 | 0.092250922509225 | 34 | 3 | 0.011070110701107 | 0 |
| OTUD7B-202 | OTUD7B | Q6GQQ9 | OTU domain-containing protein 7B | chr1 | GO:0002250 | Not Cancer Driver | No | 99 | 0.1174377224199288 | 538 | 72 | 0.0854092526690391 | 0 |
| PAG1-201 | PAG1 | Q9NWQ8 | Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 | chr8 | GO:0002250 | Not Cancer Driver | No | 44 | 0.1018518518518518 | 399 | 44 | 0.1018518518518518 | 0 |
| PDCD1-201 | PDCD1 | Q15116 | Programmed cell death protein 1 | chr2 | GO:0002250 | Not Cancer Driver | No | 45 | 0.15625 | 141 | 31 | 0.1076388888888889 | 0 |
| PDCD1LG2-201 | PDCD1LG2 | Q9BQ51 | Programmed cell death 1 ligand 2 | chr9 | GO:0002250 | Census, Compendium | Yes | 26 | 0.0952380952380952 | 42 | 8 | 0.0293040293040293 | 0 |
| PDIA3-201 | PDIA3 | P30101 | Protein disulfide-isomerase A3 | chr15 | GO:0002250 | Not Cancer Driver | No | 34 | 0.0673267326732673 | 98 | 6 | 0.0118811881188118 | 0 |
| PIK3CD-202 | PIK3CD | O00329 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | chr1 | GO:0002250 | Not Cancer Driver | No | 116 | 0.1111111111111111 | 61 | 8 | 0.0076628352490421 | 1 |
| PIK3CG-205 | PIK3CG | P48736 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | chr7 | GO:0002250 | Not Cancer Driver | No | 230 | 0.2087114337568058 | 122 | 28 | 0.0254083484573502 | 3 |
| PRDM1-203 | PRDM1 | O75626 | PR domain zinc finger protein 1 | chr6 | GO:0002250 | Census, Compendium | Yes | 122 | 0.1478787878787879 | 339 | 56 | 0.0678787878787878 | 0 |
| PRKCB-201 | PRKCB | P05771 | Protein kinase C beta type | chr16 | GO:0002250 | Census, Compendium | Yes | 153 | 0.2280178837555886 | 148 | 26 | 0.0387481371087928 | 0 |
| PRKD2-201 | PRKD2 | Q9BZL6 | Serine/threonine-protein kinase D2 | chr19 | GO:0002250 | Compendium | Yes | 89 | 0.1013667425968109 | 247 | 26 | 0.0296127562642369 | 0 |
| PRR7-201 | PRR7 | Q8TB68 | Proline-rich protein 7 | chr5 | GO:0002250 | Not Cancer Driver | No | 10 | 0.0364963503649635 | 199 | 6 | 0.0218978102189781 | 0 |
| PTK2B-201 | PTK2B | Q14289 | Protein-tyrosine kinase 2-beta | chr8 | GO:0002250 | Not Cancer Driver | No | 117 | 0.1159563924677899 | 263 | 23 | 0.0227948463825569 | 0 |
| RAG1-201 | RAG1 | P15918 | V(D)J recombination-activating protein 1 | chr11 | GO:0002250 | Not Cancer Driver | No | 161 | 0.1543624161073825 | 209 | 34 | 0.0325982742090124 | 35 |
| RAP1GAP-205 | RAP1GAP | P47736 | Rap1 GTPase-activating protein 1 | chr1 | GO:0002250 | Not Cancer Driver | No | 64 | 0.0965309200603318 | 313 | 30 | 0.0452488687782805 | 0 |
| RAP1GAP2-201 | RAP1GAP2 | Q684P5 | Rap1 GTPase-activating protein 2 | chr17 | GO:0002250 | Not Cancer Driver | No | 64 | 0.0876712328767123 | 416 | 40 | 0.0547945205479452 | 0 |
| RAPGEF3-205 | RAPGEF3 | O95398 | Rap guanine nucleotide exchange factor 3 | chr12 | GO:0002250 | Not Cancer Driver | No | 79 | 0.085590465872156 | 197 | 18 | 0.0195016251354279 | 0 |
| RAPGEF4-201 | RAPGEF4 | Q8WZA2 | Rap guanine nucleotide exchange factor 4 | chr2 | GO:0002250 | Not Cancer Driver | No | 113 | 0.1117705242334322 | 192 | 16 | 0.0158259149357072 | 0 |
| RIPK2-201 | RIPK2 | O43353 | Receptor-interacting serine/threonine-protein kinase 2 | chr8 | GO:0002250 | Not Cancer Driver | No | 43 | 0.0796296296296296 | 143 | 14 | 0.0259259259259259 | 0 |
| RNF125-201 | RNF125 | Q96EQ8 | E3 ubiquitin-protein ligase RNF125 | chr18 | GO:0002250 | Not Cancer Driver | No | 23 | 0.0991379310344827 | 27 | 1 | 0.0043103448275862 | 3 |
| RNF19B-203 | RNF19B | Q6ZMZ0 | E3 ubiquitin-protein ligase RNF19B | chr1 | GO:0002250 | Not Cancer Driver | No | 45 | 0.0614754098360655 | 344 | 20 | 0.0273224043715847 | 0 |
| SH2D1A-202 | SH2D1A | O60880 | SH2 domain-containing protein 1A | chrX | GO:0002250 | Not Cancer Driver | No | 28 | 0.21875 | 24 | 6 | 0.046875 | 19 |
| SH2D1B-201 | SH2D1B | O14796 | SH2 domain-containing protein 1B | chr1 | GO:0002250 | Not Cancer Driver | No | 24 | 0.1818181818181818 | 0 | 0 | 0.0 | 0 |
| SIGLEC10-201 | SIGLEC10 | Q96LC7 | Sialic acid-binding Ig-like lectin 10 | chr19 | GO:0002250 | Not Cancer Driver | No | 141 | 0.2022955523672883 | 311 | 71 | 0.1018651362984218 | 0 |
| SIPA1-209 | SIPA1 | Q96FS4 | Signal-induced proliferation-associated protein 1 | chr11 | GO:0002250 | Not Cancer Driver | No | 56 | 0.0537428023032629 | 671 | 41 | 0.0393474088291746 | 0 |
| SIT1-201 | SIT1 | Q9Y3P8 | Signaling threshold-regulating transmembrane adapter 1 | chr9 | GO:0002250 | Not Cancer Driver | No | 16 | 0.0816326530612244 | 122 | 6 | 0.0306122448979591 | 0 |
| SKAP1-201 | SKAP1 | Q86WV1 | Src kinase-associated phosphoprotein 1 | chr17 | GO:0002250 | Not Cancer Driver | No | 58 | 0.1615598885793872 | 132 | 24 | 0.0668523676880222 | 0 |
| SLAMF1-201 | SLAMF1 | Q13291 | Signaling lymphocytic activation molecule | chr1 | GO:0002250 | Not Cancer Driver | No | 54 | 0.1611940298507462 | 64 | 8 | 0.0238805970149253 | 0 |
| SLAMF7-203 | SLAMF7 | Q9NQ25 | SLAM family member 7 | chr1 | GO:0002250 | Not Cancer Driver | No | 43 | 0.1283582089552238 | 53 | 10 | 0.0298507462686567 | 0 |
| SYK-204 | SYK | P43405 | Tyrosine-protein kinase SYK | chr9 | GO:0002250 | Census | Yes | 75 | 0.1181102362204724 | 131 | 20 | 0.0314960629921259 | 4 |
| TAP1-201 | TAP1 | Q03518 | Antigen peptide transporter 1 | chr6 | GO:0002250 | Not Cancer Driver | No | 52 | 0.0695187165775401 | 42 | 2 | 0.0026737967914438 | 0 |
| TARM1-201 | TARM1 | B6A8C7 | T-cell-interacting, activating receptor on myeloid cells protein 1 | chr19 | GO:0002250 | Not Cancer Driver | No | 13 | 0.047970479704797 | 21 | 1 | 0.003690036900369 | 0 |
| TEC-201 | TEC | P42680 | Tyrosine-protein kinase Tec | chr4 | GO:0002250 | Census, Compendium | Yes | 66 | 0.1045958795562599 | 57 | 11 | 0.0174326465927099 | 0 |
| TFE3-201 | TFE3 | P19532 | Transcription factor E3 | chrX | GO:0002250 | Census | Yes | 44 | 0.0765217391304347 | 526 | 41 | 0.0713043478260869 | 9 |
| TFEB-204 | TFEB | P19484 | Transcription factor EB | chr6 | GO:0002250 | Census | Yes | 46 | 0.0966386554621848 | 431 | 41 | 0.0861344537815126 | 0 |
| THEMIS-201 | THEMIS | Q8N1K5 | Protein THEMIS | chr6 | GO:0002250 | Not Cancer Driver | No | 169 | 0.2636505460218408 | 111 | 33 | 0.0514820592823713 | 0 |
| TNFRSF11A-202 | TNFRSF11A | Q9Y6Q6 | Tumor necrosis factor receptor superfamily member 11A | chr18 | GO:0002250 | Not Cancer Driver | No | 61 | 0.099025974025974 | 286 | 33 | 0.0535714285714285 | 5 |
| TNFRSF13B-201 | TNFRSF13B | O14836 | Tumor necrosis factor receptor superfamily member 13B | chr17 | GO:0002250 | Not Cancer Driver | No | 42 | 0.1433447098976109 | 109 | 17 | 0.0580204778156996 | 4 |
| TNFRSF13C-201 | TNFRSF13C | Q96RJ3 | Tumor necrosis factor receptor superfamily member 13C | chr22 | GO:0002250 | Not Cancer Driver | No | 15 | 0.0815217391304347 | 128 | 13 | 0.0706521739130434 | 0 |
| TNFRSF14-201 | TNFRSF14 | Q92956 | Tumor necrosis factor receptor superfamily member 14 | chr1 | GO:0002250 | Census, Compendium | Yes | 26 | 0.0918727915194346 | 54 | 4 | 0.0141342756183745 | 0 |
| TNFRSF17-201 | TNFRSF17 | Q02223 | Tumor necrosis factor receptor superfamily member 17 | chr16 | GO:0002250 | Census | Yes | 17 | 0.092391304347826 | 1 | 0 | 0.0 | 0 |
| TNFRSF21-201 | TNFRSF21 | O75509 | Tumor necrosis factor receptor superfamily member 21 | chr6 | GO:0002250 | Not Cancer Driver | No | 72 | 0.1099236641221374 | 280 | 38 | 0.0580152671755725 | 0 |
| TNFSF18-201 | TNFSF18 | Q9UNG2 | Tumor necrosis factor ligand superfamily member 18 | chr1 | GO:0002250 | Not Cancer Driver | No | 23 | 0.1299435028248587 | 0 | 0 | 0.0 | 0 |
| TRAC-201 | TRAC | P01848 | T cell receptor alpha chain constant | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAJ3-201 | TRAJ3 | A0A075B6Y3 | T cell receptor alpha joining 3 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAJ31-201 | TRAJ31 | A0A075B700 | T cell receptor alpha joining 31 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAJ42-201 | TRAJ42 | A0A075B6Y9 | T cell receptor alpha joining 42 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAT1-201 | TRAT1 | Q6PIZ9 | T-cell receptor-associated transmembrane adapter 1 | chr3 | GO:0002250 | Not Cancer Driver | No | 68 | 0.3655913978494624 | 131 | 56 | 0.3010752688172043 | 0 |
| TRAV1-1-201 | TRAV1-1 | A0A0B4J248 | T cell receptor alpha variable 1-1 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV1-2-201 | TRAV1-2 | A0A0B4J238 | T cell receptor alpha variable 1-2 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV10-201 | TRAV10 | A0A0B4J240 | T cell receptor alpha variable 10 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV12-1-201 | TRAV12-1 | A0A0B4J245 | T cell receptor alpha variable 12-1 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV12-2-201 | TRAV12-2 | A0A075B6T6 | T cell receptor alpha variable 12-2 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV12-3-201 | TRAV12-3 | A0A0B4J271 | T cell receptor alpha variable 12-3 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV13-1-201 | TRAV13-1 | A0A0B4J241 | T cell receptor alpha variable 13-1 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV13-2-201 | TRAV13-2 | A0A0B4J235 | T cell receptor alpha variable 13-2 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV14DV4-201 | TRAV14DV4 | A0A0A6YYC5 | T cell receptor alpha variable 14/delta variable 4 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV16-201 | TRAV16 | A0A0A6YYK6 | T cell receptor alpha variable 16 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV17-201 | TRAV17 | A0A0B4J275 | T cell receptor alpha variable 17 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV18-201 | TRAV18 | A0A075B6X5 | T cell receptor alpha variable 18 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV19-201 | TRAV19 | A0A0A6YYK7 | T cell receptor alpha variable 19 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV2-201 | TRAV2 | A0A0B4J234 | T cell receptor alpha variable 2 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV20-201 | TRAV20 | A0A0B4J274 | T cell receptor alpha variable 20 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV21-201 | TRAV21 | A0A0B4J279 | T cell receptor alpha variable 21 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV22-201 | TRAV22 | A0A0B4J277 | T cell receptor alpha variable 22 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV23DV6-201 | TRAV23DV6 | A0A075B6W5 | T cell receptor alpha variable 23/delta variable 6 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV24-201 | TRAV24 | A0A0B4J272 | T cell receptor alpha variable 24 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV25-201 | TRAV25 | A0A0B4J276 | T cell receptor alpha variable 25 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV26-1-201 | TRAV26-1 | A0A087WT03 | T cell receptor alpha variable 26-1 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV26-2-201 | TRAV26-2 | A0A0B4J265 | T cell receptor alpha variable 26-2 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV27-201 | TRAV27 | A0A087WT01 | T cell receptor alpha variable 27 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV29DV5-201 | TRAV29DV5 | P04437 | T cell receptor alpha variable 29/delta variable 5 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV3-201 | TRAV3 | A0A0B4J244 | T cell receptor alpha variable 3 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV30-201 | TRAV30 | A0A087WSZ9 | T cell receptor alpha variable 30 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV34-201 | TRAV34 | A0A0B4J273 | T cell receptor alpha variable 34 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV36DV7-201 | TRAV36DV7 | A0A075B6V5 | T cell receptor alpha variable 36/delta variable 7 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV38-1-201 | TRAV38-1 | A0A0B4J264 | T cell receptor alpha variable 38-1 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV38-2DV8-201 | TRAV38-2DV8 | A0JD32 | T cell receptor alpha variable 38-2/delta variable 8 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV39-201 | TRAV39 | A0A0B4J263 | T cell receptor alpha variable 39 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV4-201 | TRAV4 | A0A0B4J268 | T cell receptor alpha variable 4 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV40-201 | TRAV40 | A0A0B4J280 | T cell receptor alpha variable 40 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV41-201 | TRAV41 | A0A0B4J266 | T cell receptor alpha variable 41 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV5-201 | TRAV5 | A0A0B4J249 | T cell receptor alpha variable 5 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV6-201 | TRAV6 | A0A075B6T7 | T cell receptor alpha variable 6 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV7-201 | TRAV7 | A0A075B6U4 | T cell receptor alpha variable 7 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV8-1-201 | TRAV8-1 | A0A0A6YYK1 | T cell receptor alpha variable 8-1 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV8-2-201 | TRAV8-2 | A0A0B4J237 | T cell receptor alpha variable 8-2 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV8-3-201 | TRAV8-3 | A0A0A6YYJ7 | T cell receptor alpha variable 8-3 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV8-4-201 | TRAV8-4 | P01737 | T cell receptor alpha variable 8-4 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV8-6-201 | TRAV8-6 | A0A0B4J262 | T cell receptor alpha variable 8-6 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV9-1-201 | TRAV9-1 | A0A075B6T8 | T cell receptor alpha variable 9-1 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRAV9-2-201 | TRAV9-2 | A0A087WT02 | T cell receptor alpha variable 9-2 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBC1-201 | TRBC1 | P01850 | T cell receptor beta constant 1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBC2-201 | TRBC2 | A0A5B9 | T cell receptor beta constant 2 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBJ1-1-202 | TRBJ1-1 | A0A0J9YXA8 | T cell receptor beta joining 1-1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBJ1-2-202 | TRBJ1-2 | A0A0J9YX06 | T cell receptor beta joining 1-2 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBJ1-3-201 | TRBJ1-3 | A0A0J9YWP8 | T cell receptor beta joining 1-3 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBJ1-4-201 | TRBJ1-4 | A0A0J9YXG5 | T cell receptor beta joining 1-4 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBJ1-5-201 | TRBJ1-5 | A0A0J9YXM7 | T cell receptor beta joining 1-5 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBJ1-6-202 | TRBJ1-6 | A0A0J9YWX3 | T cell receptor beta joining 1-6 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBJ2-1-201 | TRBJ2-1 | A0A0A0MTA7 | T cell receptor beta joining 2-1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBJ2-2-201 | TRBJ2-2 | A0A0A0MT94 | T cell receptor beta joining 2-2 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBJ2-3-201 | TRBJ2-3 | A0A0B4J200 | T cell receptor beta joining 2-3 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBJ2-4-201 | TRBJ2-4 | A0A0A0MT87 | T cell receptor beta joining 2-4 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBJ2-5-201 | TRBJ2-5 | A0A0A0MTA4 | T cell receptor beta joining 2-5 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBJ2-6-201 | TRBJ2-6 | A0A0A0MT70 | T cell receptor beta joining 2-6 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBJ2-7-201 | TRBJ2-7 | A0A0A0MT78 | T cell receptor beta joining 2-7 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV10-1-201 | TRBV10-1 | A0A0K0K1A3 | T cell receptor beta variable 10-1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV10-2-201 | TRBV10-2 | A0A0K0K1G8 | T cell receptor beta variable 10-2 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV10-3-201 | TRBV10-3 | A0A0K0K1G6 | T cell receptor beta variable 10-3 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV11-1-201 | TRBV11-1 | A0A0K0K1C0 | T cell receptor beta variable 11-1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV11-3-201 | TRBV11-3 | A0A5A6 | T cell receptor beta variable 11-3 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV12-3-201 | TRBV12-3 | P01733 | T cell receptor beta variable 12-3 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV12-4-201 | TRBV12-4 | A0A0B4J2E0 | T cell receptor beta variable 12-4 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV12-5-201 | TRBV12-5 | A0A1B0GX78 | T cell receptor beta variable 12-5 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV13-201 | TRBV13 | A0A0A6YYD4 | T cell receptor beta variable 13 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV14-201 | TRBV14 | A0A5B0 | T cell receptor beta variable 14 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV16-201 | TRBV16 | A0A087WV62 | T cell receptor beta variable 16 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV17-201 | TRBV17 | A0A087X0K7 | Probable non-functional T cell receptor beta variable 17 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV18-201 | TRBV18 | A0A087X0M5 | T cell receptor beta variable 18 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV19-201 | TRBV19 | A0A075B6N1 | T cell receptor beta variable 19 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV2-201 | TRBV2 | A0A1B0GX68 | T cell receptor beta variable 2 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV20-1-201 | TRBV20-1 | A0A075B6N2 | T cell receptor beta variable 20-1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV23-1-201 | TRBV23-1 | A0A0A0MS06 | Probable non-functional T cell receptor beta variable 23-1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV24-1-201 | TRBV24-1 | A0A075B6N3 | T cell receptor beta variable 24-1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV25-1-202 | TRBV25-1 | A0A075B6N4 | T cell receptor beta variable 25-1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV27-201 | TRBV27 | A0A0K0K1C4 | T cell receptor beta variable 27 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV28-201 | TRBV28 | A0A5B6 | T cell receptor beta variable 28 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV29-1-201 | TRBV29-1 | A0A5B7 | T cell receptor beta variable 29-1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV3-1-201 | TRBV3-1 | A0A576 | T cell receptor beta variable 3-1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV30-201 | TRBV30 | A0A0K0K1B3 | T cell receptor beta variable 30 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV4-1-201 | TRBV4-1 | A0A577 | T cell receptor beta variable 4-1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV4-2-201 | TRBV4-2 | A0A539 | T cell receptor beta variable 4-2 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV5-1-201 | TRBV5-1 | A0A578 | T cell receptor beta variable 5-1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV5-3-201 | TRBV5-3 | A0A0A0MS03 | Probable non-functional T cell receptor beta variable 5-3 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV5-4-201 | TRBV5-4 | A0A0C4DH59 | T cell receptor beta variable 5-4 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV5-5-201 | TRBV5-5 | A0A597 | T cell receptor beta variable 5-5 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV5-6-201 | TRBV5-6 | A0A599 | T cell receptor beta variable 5-6 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV5-7-201 | TRBV5-7 | A0A0A0MS05 | Probable non-functional T cell receptor beta variable 5-7 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV6-1-201 | TRBV6-1 | A0A0K0K1D8 | T cell receptor beta variable 6-1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV6-2-202 | TRBV6-3 | P0DPF7 | T cell receptor beta variable 6-3 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV6-4-201 | TRBV6-4 | A0A1B0GX49 | T cell receptor beta variable 6-4 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV6-5-201 | TRBV6-5 | A0A0K0K1A5 | T cell receptor beta variable 6-5 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV6-6-201 | TRBV6-6 | A0A0A6YYG2 | T cell receptor beta variable 6-6 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV6-7-201 | TRBV6-7 | A0A0A0MS04 | Probable non-functional T cell receptor beta variable 6-7 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV6-8-201 | TRBV6-8 | A0A0A6YYG3 | T cell receptor beta variable 6-8 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV7-1-201 | TRBV7-1 | A0A0A6YYK4 | Probable non-functional T cell receptor beta variable 7-1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV7-2-202 | TRBV7-2 | A0A1B0GXF2 | T cell receptor beta variable 7-2 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV7-3-201 | TRBV7-3 | A0A075B6L6 | Probable non-functional T cell receptor beta variable 7-3 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV7-4-201 | TRBV7-4 | A0A1B0GX95 | T cell receptor beta variable 7-4 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV7-6-201 | TRBV7-6 | A0A1B0GX31 | T cell receptor beta variable 7-6 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV7-7-201 | TRBV7-7 | A0A0K0K1E9 | T cell receptor beta variable 7-7 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV7-9-201 | TRBV7-9 | P04435 | T cell receptor beta variable 7-9 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRBV9-201 | TRBV9 | A0A0B4J1U6 | T cell receptor beta variable 9 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRDC-201 | TRDC | B7Z8K6 | T cell receptor delta constant | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRDJ1-201 | TRDJ1 | A0A075B706 | T cell receptor delta joining 1 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRDV1-201 | TRDV1 | A0A1B0GX56 | T cell receptor delta variable 1 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRDV2-201 | TRDV2 | A0JD36 | T cell receptor delta variable 2 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRDV3-201 | TRDV3 | A0JD37 | T cell receptor delta variable 3 | chr14 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TREM1-201 | TREM1 | Q9NP99 | Triggering receptor expressed on myeloid cells 1 | chr6 | GO:0002250 | Not Cancer Driver | No | 36 | 0.1538461538461538 | 63 | 5 | 0.0213675213675213 | 0 |
| TRGC1-201 | TRGC1 | P0CF51 | T cell receptor gamma constant 1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRGC2-201 | TRGC2 | P03986 | T cell receptor gamma constant 2 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRGJ1-201 | TRGJ1 | A0A075B6S0 | T cell receptor gamma joining 1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRGJ2-201 | TRGJ1 | A0A075B6S0 | T cell receptor gamma joining 1 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRGV1-201 | TRGV1 | A0A0A0MS02 | Probable non-functional T cell receptor gamma variable | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRGV2-201 | TRGV2 | A0A075B6R0 | T cell receptor gamma variable 2 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRGV3-201 | TRGV3 | P03979 | T cell receptor gamma variable 3 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRGV4-201 | TRGV4 | A0A0C4DH28 | T cell receptor gamma variable 4 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRGV5-201 | TRGV5 | A0A0B4J1U4 | T cell receptor gamma variable 5 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRGV8-201 | TRGV8 | A0A0C4DH27 | T cell receptor gamma variable 8 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRGV9-201 | TRGV9 | Q99603 | T cell receptor gamma variable 9 | chr7 | GO:0002250 | Not Cancer Driver | No | 0 | 0.0 | 0 | 0 | 0.0 | 0 |
| TRPM4-201 | TRPM4 | Q8TD43 | Transient receptor potential cation channel subfamily M member 4 | chr19 | GO:0002250 | Not Cancer Driver | No | 124 | 0.1021416803953871 | 149 | 17 | 0.0140032948929159 | 12 |
| TSC1-201 | TSC1 | Q92574 | Hamartin | chr9 | GO:0002250 | Census, Compendium | Yes | 94 | 0.0807560137457044 | 735 | 53 | 0.0455326460481099 | 11 |
| TXK-201 | TXK | P42681 | Tyrosine-protein kinase TXK | chr4 | GO:0002250 | Not Cancer Driver | No | 60 | 0.1138519924098671 | 61 | 4 | 0.0075901328273244 | 0 |
| VTCN1-203 | VTCN1 | Q7Z7D3 | V-set domain-containing T-cell activation inhibitor 1 | chr1 | GO:0002250 | Not Cancer Driver | No | 32 | 0.1134751773049645 | 3 | 2 | 0.0070921985815602 | 0 |
| ZAP70-201 | ZAP70 | P43403 | Tyrosine-protein kinase ZAP-70 | chr2 | GO:0002250 | Not Cancer Driver | No | 90 | 0.1453957996768982 | 119 | 13 | 0.0210016155088853 | 7 |
| ZNF683-202 | ZNF683 | Q8IZ20 | Tissue-resident T-cell transcription regulator protein ZNF683 | chr1 | GO:0002250 | Not Cancer Driver | No | 67 | 0.1278625954198473 | 203 | 26 | 0.049618320610687 | 0 |